During the progression of ALS, microglia, astrocytes, and motor neurons continue the pro-inflammatory cross-talk, inter alia through P2X7 activation that was shown to be prevented by P2X7 antagonists [62, 75]. This evidence concerns the gene P2RX7 and amyotrophic lateral sclerosis.